Neuroendocrine Tumors Market 2020 Industry Share, Trends, Growth, Key Leaders Analysis, Segmentation, Emerging Technology by Regional Forecast to 2027

When globalization is growing day by day, many businesses call for global market research consisting of actionable market insights that helps with decision making. This Neuroendocrine Tumors Market analysis report gives out the data for industry about company profile, product specifications, capacity, production value, and market shares for each company for the year 2020 to 2026 under the competitive analysis study. The business report is prepared with the systematic gathering and analysis of information about individuals or organizations which is carried out through social and opinion research. Neuroendocrine Tumors Market research report provides a lot for the business and bestows with the solution for the critical or complex business problems.

Request for FREE sample copy or PDF Here @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-neuroendocrine-tumors-market

The credible Neuroendocrine Tumors Market report brings into focus several aspects related to industry and market. Few of these can be given here as market definition, market segmentation, competitive analysis and research methodology. In addition, the uniqueness of respondents is kept secretive and no promotional approach is made to them while analysing the data. This market document displays better market insights with which driving the business into right direction becomes simple and easy. Businesses can surely look forward to the reduced risk of failure with this all inclusive market research report. This global Neuroendocrine Tumors Market report evaluates chief factors of the market which provides precise data and information for the business growth.

Global neuroendocrine tumors market is rise gradually to an estimated value of USD 2.80 Billion by 2026 registering a CAGR of 10.2% in the forecast period of 2019-2026. Increasing prevalence of neuroendocrine tumors and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.

Few of the major competitors currently working in the global neuroendocrine tumors market are, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Amgen, Inc.,  Ipsen Pharma, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Mylan N.V, Sanofi S.A, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eli Lilly and Company, AbbVie Inc., Advanced Accelerator Applications and among others

Browse Detailed TOC Here @ https://www.databridgemarketresearch.com/toc?dbmr=global-neuroendocrine-tumors-market

Market Definition: Global Neuroendocrine Tumors Market

Neuroendocrine tumors are an oncology disorder in which cancer arises from neuroendocrine cells and proliferate almost all over the body. The organs affected by neuroendocrine tumors are mainly, gastrointestinal (GI) tract, gallbladder, pancreas, lungs and thyroid. It is seen rarely in thymus, kidneys, liver, prostate, skin and ovaries. The patient may experience indigestion, abdominal pain, difficulty in breathing, muscle weakness, jaundice, weight loss etc.

According to the statistics published in American Society of Clinical Oncology, the total prevalent population of neuroendocrine tumors in United States was over 170,000, it is estimated that 12,000 new cases of patients in United States diagnosed with neuroendocrine tumors each year.

Key Developments in the Market:

In January 2018, Advanced Accelerator Applications received FDA approval for Lutathera (lutetium Lu 177 dotatate), a radioactive somatostatin receptor acting as a Peptide Receptor Radionuclide Therapy (PRRT), indicated for the treatment of adult patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Previously, drug also received Orphan Drug designation by both the US FDA and European Medicines Agency (EMA)

In April 2019, Merck & Co., Inc received expanded approval from the US FDA for Keytruda (pembrolizumab), an anti-PD-1 therapy as a first line treatment of patients with stage III non-small cell lung cancer

Segmentation: Global Neuroendocrine Tumors Market

Neuroendocrine Tumors Market : By Site of Origin

Carcinoid tumors in the lungs
Pancreatic neuroendocrine tumors
Medullary thyroid carcinoma
Merkel cell carcinoma
Pheochromocytoma of the adrenal gland
Small cell lung cancer
Large cell lung cancer
Others

Neuroendocrine Tumors Market : By Therapy Type

Chemotherapy
Hormonal therapy
Immunotherapy
Surgery
Medication
Others

Neuroendocrine Tumors Market : By Mechanism of Cation type

Somatostatin analogs
Tyrosine kinase inhibitor
Peptide receptor radionuclide
Alfa-interferon
Proton-pump inhibitors
Others

Neuroendocrine Tumors Market : By Drug Type

Everolimus
Sunitinib malate
Lorlatinib
Nivolumab
Dacomitinib
Brigatinib
Durvalumab
Atezolizumab
Alectinib
Crizotinib
Topotecan hydrochloride
Bevacizumab
Others

Neuroendocrine Tumors Market : By Route of administration

Oral
Intravenous
Others

Neuroendocrine Tumors Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

Neuroendocrine Tumors Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Report Highlights:

Shifting Industry dynamics
In-depth Neuroendocrine Tumors Market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies for key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Neuroendocrine Tumors Market Reports - Table of Contents
1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neuroendocrine Tumors Market
4. Market Overview
    4.1. Introduction
    4.2. Overview
    4.3. Market Dynamics
    4.4. Porter’s Five Force Analysis
5. Key Insights
    5.1. Technological Advancements
    5.2. Pricing Analysis
    5.3. Recent Developments
6. Global Neuroendocrine Tumors Market Analysis and Forecast, By Product
7. Global Neuroendocrine Tumors Market Analysis and Forecast, By Detector
8. Global Neuroendocrine Tumors Market Analysis and Forecast, By Technology
9. Global Neuroendocrine Tumors Market Analysis and Forecast, By Application
10. Global Neuroendocrine Tumors Market Analysis and Forecast, By End-user
11. Global Neuroendocrine Tumors Market Analysis and Forecast, By Region
12. North America Neuroendocrine Tumors Market Analysis and Forecast
13. Europe Neuroendocrine Tumors Market Analysis and Forecast
14. Asia Pacific Neuroendocrine Tumors Market Analysis and Forecast
15. Latin America Neuroendocrine Tumors Market Analysis and Forecast
16. Middle East & Africa Neuroendocrine Tumors Market Analysis and Forecast
17. Competitive Landscape

Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-neuroendocrine-tumors-market

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.